Singapore: HUYA Bioscience International has entered into a collaborative partnership with Shanghai Zhangjiang Biotech a...
Singapore: India-based Zydus Cadila and Pieris, a next generation therapeutic protein R&D company, have entered int...
Singapore: Kowa Pharmaceuticals America and Eli Lilly and Company revealed results of the PREVAIL study that was held in...
Singapore: Aslan Pharmaceuticals, Singapore biotech company focused on the development of immunotherapies and targeted ...
Singapore: Boehringer Ingelheim has recieved 'breakthrough therapy' designation from US Food & Drug Administration (...
Singapore: Onco Therapies Limited, a wholly-owned subsidiary ofStrides Arcolab, received final abbreviated new drug appl...
Singapore: Professor Alex Matter, CEO, Experimental Therapeutics Centre (ETC), A*STAR, Singapore, has been awarded the 8...
Singapore: China based Ascletis has received Taiwan Food and Drug Administration (TFDA) approval to start phase II clini...
Singapore: China based 3SBio has entered into an exclusive licensing deal with Korea's PharmAbcine for the development, ...
Singapore: Increased use of targeted therapies, along with a greater uptake of branded drugs and rising incidence popula...
Singapore: Global pharmaceutical company, Bristol-Myers Squibb, and California Institute for Biomedical Research (Calibr...
New Delhi: In an innovative approach to spread awareness about the need for researching new drugs for TB, OSDD, India's ...
Singapore: Australian drug discovery firm, Imugene, has appointed Mr Charles Walker as Chief Executive Officer of Imugen...
Singapore: Rapid growth in microRNA (miRNA) research over the past two years, which is fuelled by its diagnostic and the...
Singapore: VolitionRx, focused on developing blood-based diagnostic tests for a broad range of cancer types and other co...
Singapore: Japan's firm, Otsuka Pharmaceutical, has established a direct presence in Sydney, Australia, to bring innovat...
Singapore: The global prophylactic human papillomavirus (HPV) vaccine market value is forecast to experience moderate gr...
Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2....
